Skip to Main Content

The (POGO) Blog

March 23, 2017

By Ari Goldberg

POGO: GSA Ruling on Trump Hotel Lease Should Be Challenged



Trump International Hotel in Washington, DC POGO General Counsel Scott Amey challenges the General Services Administration’s conclusion that the Trump International Hotel in Washington, DC does not violate the terms of the lease forbidding a benefit to elected officials.

Continue Reading POGO: GSA Ruling on Trump Hotel Lease Should Be Challenged

Topics: Government Accountability

March 23, 2017

By Iulia Gheorghiu

Vacancies Leave Whistleblowers Vulnerable



President Trump speaks with German Chancellor Merkel from the Oval Office. He is on the phone with a staffer seated before him and several other empty seats. To bolster federal oversight and ensure the protection of whistleblowers, President Donald Trump needs to fill positions in Offices of Inspectors General, the Office of Special Counsel, and the Merit Systems Protection Board.

Continue Reading Vacancies Leave Whistleblowers Vulnerable

Topics: Government Accountability, Whistleblower Protections

March 13, 2017

By Lydia Dennett

Justice Dept. Improves Access to Foreign Lobbying Documents



A shot of various foreign banknotes and coins The Department of Justice has made a key set of foreign lobbying documents available online for the first time. American lobbyists working on behalf of foreign governments or political parties are required to file these documents, known as informational ma

Continue Reading Justice Dept. Improves Access to Foreign Lobbying Documents

Topics: Government Accountability, Open Government

March 13, 2017

By Nick Schwellenbach

Trump’s Trademarks Pose Ethics Challenge for the Executive Branch



Trump President Trump has trademark litigation before an executive branch panel—these judges ultimately work for Trump. Can they neutrally preside over a case involving him?

Continue Reading Trump’s Trademarks Pose Ethics Challenge for the Executive Branch

Topics: Government Accountability

March 3, 2017

By David S. Hilzenrath

Trump’s Dangerous Prescription for the FDA



President Trump addressing a joint session of Congress, with VP Mike Pence and Rep. Paul Ryan seated behind him, clapping. President Donald Trump called the FDA drug approval process slow and burdensome, but the evidence he cited could point to the opposite conclusion. Slashing regulatory restraints as he proposed could pose medical and financial hazards.

Continue Reading Trump’s Dangerous Prescription for the FDA

Topics: Government Accountability, Open Government, Public Health and Science

Items 51 - 55 of 100  Previous11121314151617181920Next

Browse POGOBlog by Topic

POGO on Facebook